SARomics Biostructures AB: SARomics Biostructures AB, founded in 2006 and headquartered in Sweden, specializes in offering an array of structural biology and drug discovery services. Their expertise includes X-ray crystallography and protein NMR spectroscopy, along with fragment screening and structure-based drug design services. The company's capabilities comprise protein cloning, expression, crystallization, fragment screening, and higher-order structure analysis of biosimilars. Notably, SARomics Biostructures AB received a Venture Round investment on 08 September 2020 from LU Innovation.
General Information
Get notified when SARomics Biostructures AB moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track SARomics Biostructures AB
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Sweden Market
Biotechnology
About SARomics Biostructures AB
Taxonomy: Protein Crystallography, Drug Discovery, X-ray Crystallography, NMR Spectroscopy, Fragment Screening, Structure-based Drug Design, Computational Chemistry, Antibody Structure Determination, Biosimilars Analysis, Synchrotron, Pharmaceutical Services, Molecular Biology, Protein Optimization, Compound Screening, Medicon Village
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 | •••• •••• | 08 Sep 2020 |
| Venture Round | •••••• | - | 06 Mar 2014 | |
| Venture Round | •••••• | 3 |
|
25 Oct 2012 |
SARomics Biostructures AB Alternatives & Competitors
The global structural, physicochemical and biophysical characterization experts
FAQ About SARomics Biostructures AB
Don't just browse. Track.
Signal Tracker monitors SARomics Biostructures AB and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.